The multicenter observational study for the prevalence of HIV-associated neurocognitive disorder (HAND) in Japa

Not Applicable

• Conditions: HIV-associated neurocognitive disorder

• Registration Number: JPRN-UMIN000015357
• Lead Sponsor: AIDS Clinical Center , National Center for Global Health and Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-10-08
• Study Completion: 2016-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Not provided

Exclusion Criteria

Active AIDS-defining disease. Congenital developmental retardation Definitive diagnosis of following diseases; Mental disorder, such as major depressive disorder, schizophrenia. Alzheimer's disease, Frontotemporallobar degeneration, Lewy-body disease, Vascular disease, Traumatic brain injury, Prion disease, Parkinson's disease, Huntington's disease. Another functional disorder (Epilepsy) Illegal substance use Severe alcoholism Endocrine disorder (hypothyroidism, Wernicke encephalopathy, Vitamin B12 deficiency) Current treatment or severe sequelae of CNS opportunistic infections Symptoms of a current, active infection a body temperature of >38.5 at the time of recruitment Experience of neuropsychiatric test within past 1 year Other inappropriate condition for neuropsychiatric test

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalence of HIV-associated neurocognitive disorder in Japan

Secondary Outcome Measures

Name	Time	Method
The evaluation of risk and confounding factors for neuropsychiatric scores.